Related Experiment Videos

The T lymphocyte insulin receptor in diabetes and obesity: an intrinsic binding defect

J H Helderman, P Raskin

|July 1, 1980

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The effect of basal-bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis.

Diabetic medicine : a journal of the British Diabetic Association·2018

Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study).

Diabetes, obesity & metabolism·2016

AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes.

Diabetes, obesity & metabolism·2015

Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial.

Diabetes, obesity & metabolism·2011

Rapid murine mixed lymphocyte cultures assessed by emergence of T-cell insulin receptors.

Immunogenetics·2011

Glycaemic control with liraglutide: the phase 3 trial programme.

International journal of clinical practice. Supplement·2010

See all related articles